← Open Payments lookup

ELSA CORREA: Open Payments

NPI 1487620423 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,810 in 93 payments from 12 companies in 2025. Trend: 2023 $1,374 · 2024 $1,928 · 2025 $1,810

Food & beverage: $1,653Education: $157
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$356
Alkermes, Inc.20$332
Neurocrine BioSciences, Inc.16$247
ABBVIE INC.15$185
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$147
Axsome Therapeutics, Inc.4$113
Lundbeck LLC5$112
Vanda Pharmaceuticals Inc.3$91
Otsuka America Pharmaceutical, Inc.5$82
Corium, LLC2$63

Products named: ARISTADA, INGREZZA, VRAYLAR, UZEDY, REXULTI, CAPLYTA, FANAPT, Auvelity.

Industry payments across MD — which companies pay providers there.